Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (431-440 of 487) with videos related to

Pageof 49
Sort By:
British Journal of Haematology|February 26, 2013
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacyDavid J Kuter, James B Bussel, Adrian Newland, et al.
Blood|August 20, 2020
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter studyMarc Michel, Marco Ruggeri, Tomas Jose Gonzalez-Lopez, et al.
British Journal of Haematology|March 31, 2023
A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemiaYulia Lin, M Elisabeth Del Giudice, Amie Kron, et al.
American Journal of Hematology|August 19, 2014
Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopeniaWilliam Beau Mitchell, Mariana P Pinheiro, Nayla Boulad, et al.
Blood Advances|September 4, 2020
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaTadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, et al.
American Journal of Hematology|February 19, 2021
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccinationEun-Ju Lee, Douglas B Cines, Terry Gernsheimer, et al.
The New England Journal of Medicine|November 30, 2007
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraJames B Bussel, Gregory Cheng, Mansoor N Saleh, et al.
Pediatric Blood & Cancer|March 25, 2021
Quality of life is an important indication for second-line treatment in children with immune thrombocytopeniaKristin A Shimano, Cindy Neunert, James B Bussel, et al.
Haematologica|April 22, 2014
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years durationJames B Bussel, Christina S Lee, Caroline Seery, et al.
Blood|August 5, 2020
Identification of occult cerebral microbleeds in adults with immune thrombocytopeniaNichola Cooper, Melanie A Morrison, Camelia Vladescu, et al.
Pageof 49

Showing results (431-440 of 487) with videos related to

Sort By:
Pageof 49
British Journal of Haematology|February 26, 2013
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacyDavid J Kuter, James B Bussel, Adrian Newland, et al.
Blood|August 20, 2020
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter studyMarc Michel, Marco Ruggeri, Tomas Jose Gonzalez-Lopez, et al.
British Journal of Haematology|March 31, 2023
A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemiaYulia Lin, M Elisabeth Del Giudice, Amie Kron, et al.
American Journal of Hematology|August 19, 2014
Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopeniaWilliam Beau Mitchell, Mariana P Pinheiro, Nayla Boulad, et al.
Blood Advances|September 4, 2020
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaTadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, et al.
American Journal of Hematology|February 19, 2021
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccinationEun-Ju Lee, Douglas B Cines, Terry Gernsheimer, et al.
The New England Journal of Medicine|November 30, 2007
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraJames B Bussel, Gregory Cheng, Mansoor N Saleh, et al.
Pediatric Blood & Cancer|March 25, 2021
Quality of life is an important indication for second-line treatment in children with immune thrombocytopeniaKristin A Shimano, Cindy Neunert, James B Bussel, et al.
Haematologica|April 22, 2014
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years durationJames B Bussel, Christina S Lee, Caroline Seery, et al.
Blood|August 5, 2020
Identification of occult cerebral microbleeds in adults with immune thrombocytopeniaNichola Cooper, Melanie A Morrison, Camelia Vladescu, et al.
Pageof 49